Artículos con órdenes de acceso público - Raymond ChungMás información
TotalNIHDFGEuropean CommissionVAHHMINSFCMRCAHAWellcomeDoDINSERMNSFSNSFNIHRGatesCPRITANRCZINHMRCCIHRDoris Duke Charitable FoundationLeducq Foundation, USAHRBKnut and Alice Wallenberg FoundationCancer Research UKGobierno de EspañaAlex's Lemonade StandDOEGBMFNSERCBHFParkinson's UKMultiple Sclerosis Society, UKSTFCNRFRCNBMBFKNAWGovernment of ItalyTUBITAKRWJFAIRC Foundation for Cancer Research in ItalyHealth Data Research, UK
No disponibles en ningún lugar: 26
Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection
RC Hoogeveen, MP Robidoux, T Schwarz, L Heydmann, JA Cheney, ...
Gut 68 (5), 893-904, 2019
Órdenes: US National Institutes of Health, Royal Netherlands Academy of Arts and Sciences
Direct-acting antiviral therapy for chronic HCV infection results in liver stiffness regression over 12 months post-treatment
J Chan, N Gogela, H Zheng, S Lammert, T Ajayi, Z Fricker, AY Kim, ...
Digestive diseases and sciences 63, 486-492, 2018
Órdenes: US National Institutes of Health
Acute liver injury and acute liver failure from mushroom poisoning in N orth A merica
CJ Karvellas, H Tillman, AA Leung, WM Lee, ML Schilsky, B Hameed, ...
Liver International 36 (7), 1043-1050, 2016
Órdenes: US National Institutes of Health
Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study
ED Bethea, K Gaj, JL Gustafson, A Axtell, T Lebeis, M Schoenike, ...
The lancet Gastroenterology & hepatology 4 (10), 771-780, 2019
Órdenes: US National Institutes of Health
Sofosbuvir‐based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES
AA Butt, P Yan, OS Shaikh, RT Chung, KE Sherman, ERCHIVES study
Liver International 36 (5), 651-658, 2016
Órdenes: US Department of Veterans Affairs
Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop
A Monto, RT Schooley, JC Lai, MS Sulkowski, RT Chung, JM Pawlotsky, ...
Official journal of the American College of Gastroenterology| ACG 105 (5 …, 2010
Órdenes: US National Institutes of Health
Dynamic changes in innate immune responses during direct‐acting antiviral therapy for HCV infection
JA Holmes, C Carlton‐Smith, AY Kim, EO Dumas, J Brown, JL Gustafson, ...
Journal of Viral Hepatitis 26 (3), 362-372, 2019
Órdenes: US National Institutes of Health
Cardiovascular risk reduction in patients with nonalcoholic fatty liver disease: the potential role of ezetimibe
TG Simon, KE Corey, RT Chung, R Giugliano
Digestive diseases and sciences 61, 3425-3435, 2016
Órdenes: US National Institutes of Health
Entry inhibitors and future treatment of hepatitis C
I Fofana, N Jilg, RT Chung, TF Baumert
Antiviral research 104, 136-142, 2014
Órdenes: National Institute of Health and Medical Research, France, European Commission
Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir‐based regimens: results from ERCHIVES
AA Butt, P Yan, OS Shaikh, RT Chung, KE Sherman, ERCHIVES study
Liver International 36 (9), 1275-1283, 2016
Órdenes: US Department of Veterans Affairs
Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients
ME Sise, DF Chute, JL Gustafson, D Wojciechowski, N Elias, RT Chung, ...
Hemodialysis International 22, S71-S80, 2018
Órdenes: US National Institutes of Health
Discontinuity of care for mothers with chronic hepatitis B diagnosed during pregnancy
R Rajbhandari, K Barton, AC Juncadella, AK Rubin, T Ajayi, Y Wu, ...
Journal of Viral Hepatitis 23 (7), 561-568, 2016
Órdenes: US National Institutes of Health
Reduced albumin dosing during large-volume paracentesis is not associated with adverse clinical outcomes
KB Johnson, JL Mueller, TG Simon, H Zheng, LY King, RS Makar, ...
Digestive Diseases and Sciences 60, 2190-2195, 2015
Órdenes: US National Institutes of Health
Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study
S Gawrieh, JE Lake, P Debroy, JA Sjoquist, M Robison, M Tann, F Akisik, ...
Hepatology 78 (2), 578-591, 2023
Órdenes: US National Institutes of Health
The risk of hepatitis C virus recurrence in hepatitis C virus‐infected patients treated with direct‐acting antivirals after achieving a sustained virological response: A …
P Huang, Y Wang, M Yue, Z Ge, X Xia, AJ Jeyarajan, JA Holmes, R Yu, ...
Liver International 41 (10), 2341-2357, 2021
Órdenes: US National Institutes of Health, National Natural Science Foundation of China
Changes in serum hepatitis B surface and e antigen, interferon‐inducible protein 10, and aminotransferase levels during combination therapy of immune‐tolerant chronic hepatitis B
R Perrillo, HHS Lin, KB Schwarz, P Rosenthal, M Lisker‐Melman, ...
Hepatology 76 (3), 775-787, 2022
Órdenes: US National Institutes of Health
Implementation of a controlled human infection model for evaluation of HCV vaccine candidates
E Barnes, GS Cooke, GM Lauer, RT Chung
Hepatology 77 (5), 1757-1772, 2023
Órdenes: US National Institutes of Health, UK Medical Research Council, National …
Serum HMGB1 associates with liver disease and predicts readmission and mortality in patients with alcohol use disorder
AGL Vannier, B Wardwell, V Fomin, A PeBenito, N Wolczynski, S Piaker, ...
Alcohol 95, 37-43, 2021
Órdenes: US National Institutes of Health
Current guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patients
ER Feeney, RT Chung, Y Yazdanpanah
Current Opinion in HIV and AIDS 10 (5), 323-329, 2015
Órdenes: US National Institutes of Health
Clinical significance of quantitative e antigen in a cohort of hepatitis B virus‐infected children and adults in North America
SL Cooper, WC King, DB Mogul, MG Ghany, KB Schwarz, ...
Journal of Viral Hepatitis 28 (7), 1042-1056, 2021
Órdenes: US National Institutes of Health
La información de publicación y financiación se determina de forma automática mediante un programa informático